Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,895 | 109 | 95.7% |
| Education | $85.00 | 1 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $223.34 | 13 | $0 (2021) |
| Amgen Inc. | $182.92 | 11 | $0 (2019) |
| PFIZER INC. | $182.33 | 15 | $0 (2019) |
| Novo Nordisk Inc | $180.13 | 6 | $0 (2024) |
| Astellas Pharma US Inc | $165.50 | 5 | $0 (2018) |
| GlaxoSmithKline, LLC. | $152.88 | 7 | $0 (2018) |
| PORTOLA PHARMACEUTICALS, LLC | $136.81 | 1 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $90.47 | 5 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $84.54 | 6 | $0 (2019) |
| Shire North American Group Inc | $76.96 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $139.75 | 2 | Novo Nordisk Inc ($119.92) |
| 2021 | $83.04 | 1 | AstraZeneca Pharmaceuticals LP ($83.04) |
| 2020 | $136.81 | 1 | PORTOLA PHARMACEUTICALS, LLC ($136.81) |
| 2019 | $532.88 | 34 | Amgen Inc. ($146.16) |
| 2018 | $694.63 | 46 | Astellas Pharma US Inc ($142.56) |
| 2017 | $393.18 | 26 | GlaxoSmithKline, LLC. ($131.05) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $119.92 | General |
| 04/27/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/18/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $83.04 | General |
| Category: Respiratory | ||||||
| 03/13/2020 | PORTOLA PHARMACEUTICALS, LLC | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $136.81 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 10/02/2019 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $90.24 | General |
| Category: Bone Health | ||||||
| 09/19/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Hypertriglyceridemia | ||||||
| 09/12/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/05/2019 | PFIZER INC. | PREVNAR - 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: VACCINES | ||||||
| 09/05/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/27/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/26/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Diabetes | ||||||
| 08/22/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: Diabetes | ||||||
| 08/21/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $9.52 | General |
| Category: Neuroscience | ||||||
| 08/16/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/14/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $4.32 | General |
| Category: Bone Health | ||||||
| 08/12/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/31/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $9.69 | General |
| Category: Neuroscience | ||||||
| 07/24/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Hypertriglyceridemia | ||||||
| 07/16/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/10/2019 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug), Cotempla XR-ODT | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: ADHD | ||||||
| 07/01/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/25/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/24/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: RESPIRATORY | ||||||
| 05/22/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: Neuroscience | ||||||
| 05/01/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 16 | 16 | $3,040 | $1,397 |
| 2021 | 2 | 120 | 123 | $20,826 | $11,606 |
| 2020 | 2 | 98 | 104 | $18,176 | $8,260 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 16 | 16 | $3,040 | $1,397 | 45.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 68 | 70 | $13,300 | $7,653 | 57.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 52 | 53 | $7,526 | $3,953 | 52.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 66 | 71 | $13,490 | $6,216 | 46.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 32 | 33 | $4,686 | $2,043 | 43.6% |
About Dr. Laura Rife, M.D
Dr. Laura Rife, M.D is a Family Medicine healthcare provider based in Shelbyville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932214798.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laura Rife, M.D has received a total of $1,980 in payments from pharmaceutical and medical device companies, with $139.75 received in 2024. These payments were reported across 110 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($1,895).
As a Medicare-enrolled provider, Rife has provided services to 234 Medicare beneficiaries, totaling 243 services with total Medicare billing of $21,262. Data is available for 3 years (2020–2022), covering 5 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Shelbyville, IN
- Active Since 08/20/2006
- Last Updated 03/07/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1932214798
Products in Payments
- ANDEXXA (Biological) $136.81
- FARXIGA (Drug) $117.16
- EVENITY (Biological) $100.12
- BEXSERO (Biological) $99.78
- CHANTIX (Drug) $87.33
- ENTRESTO (Drug) $84.54
- BREZTRI (Drug) $83.04
- Utibron (Drug) $75.90
- PREVNAR - 13 (Biological) $73.72
- MYRBETRIQ (Drug) $57.56
- Adzenys XR-ODT (Drug) $52.31
- MYDAYIS (Drug) $49.46
- XARELTO (Drug) $48.71
- ANORO (Drug) $42.31
- Aimovig (Biological) $40.47
- Vascepa (Drug) $39.96
- XIFAXAN (Drug) $39.66
- LINZESS (Drug) $38.96
- Prolia (Biological) $30.14
- ELIQUIS (Drug) $27.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Shelbyville
Dr. Ron Creque, Md, MD
Family Medicine — Payments: $15,710
Paul Goodlett, Md, MD
Family Medicine — Payments: $14,867
Dr. David Oligschlaeger, D.o, D.O
Family Medicine — Payments: $11,457
Beth Buchanan, Md, MD
Family Medicine — Payments: $10,835
Dr. Emily Ann Andaya, Md, MD
Family Medicine — Payments: $8,149
Meredith Kehrer, Md, MD
Family Medicine — Payments: $6,265